Skip to main content

PGT-M conditions

This table shows all PGT-M conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgtm@hfea.gov.uk.

Download full approved condition list.

Condition name Status OMIM number Documents
Episodic Ataxia Type 2 (EA2) approved 108500
Episodic Kinesigenic Dyskinesia type1 (EKD1) approved 128200
Facioscapulohumeral Muscular Dystrophy (FSHD1) approved 158900
Facioscapulohumeral Muscular Dystrophy Type 2 (FSHD2) approved 158901
Factor XIII deficiency approved 613225
Familial Adenomatous polyposis 1 (FAP1) approved 175100
Familial Adenomatous Polyposis 2 (FAP2) (MUTYH-associated polyposis) approved 608456
Familial Creutzfeldt-Jakob disease (fCJD), approved 123400
Familial Dysautonomia approved 223900
Familial Fatal Insomnia approved 600072
Familial Haemophagocytic Lymphohistiocytosis type 3 (FHL3) approved 608898
Familial Haemophagocytic Lymphohistiocytosis type 4 approved 603552
Familial Hemophagocytic Lymphohistiocytosis (FHL) approved 603553
Familial Hemophagocytic Lymphohistiocytosis 5 (FHL5) approved 613101
Familial Hypertrophic Cardiomyopathy 4 (CMH4) approved 115197
Familial Hypertrophic Cardiomyopathy type 1, 3, 7 and 10 (CMH1 , CMH3, CMH7, CMH10) approved 192600, 115196, 613690, 608758
Familial Infantile Myoclonic Epilepsy (FIME) approved 605021
Familial Juvenile Hyperuricemic Nephropathy 1 (HNFJ1) approved 162000
Familial Myelodysplastic Syndrome approved 614286
Familial Paranganglioma Syndrome (PGL1) approved 168000